World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
121
Citations
51135
World Ranking
535
National Ranking
319

Medicine

D-Index
122
Citations
51967
World Ranking
3493
National Ranking
1922

Aysegul A. Sahin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Aysegul A. Sahin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 518 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Aysegul A. Sahin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Aysegul A. Sahin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 122 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Aysegul A. Sahin is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medical and molecular biology fields, with a significant emphasis on oncology and cancer research.

Their recent publications cover a range of topics related to cancer biology and pathology, including the classification and markers of breast carcinoma and mechanisms of tumor immune regulation. Notable papers include:

  • "The 2019 World Health Organization classification of tumours of the breast," 2020, Histopathology
  • "TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer," 2020, Modern Pathology
  • "TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma," 2022, Human Pathology
  • "CD8+ T cells inhibit metastasis and CXCL4 regulates its function," 2021, British Journal of Cancer
  • "Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion," 2023, Science Advances

The scientist collaborates frequently with several researchers, including:

  • Lei Huo
  • Qingqing Ding
  • Hui Chen
  • Constance T. Albarracin
  • Kelly K. Hunt

Publications by Aysegul A. Sahin often appear in the following venues:

  • Cancer Research
  • Human Pathology
  • Cancers
  • Modern Pathology
  • Clinical Cancer Research

Their research spans multiple fields of study, predominantly:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of focus include:

  • Oncology
  • Cancer Research
  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Major research topics covered by their work are:

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • HER2/EGFR in Cancer Research
  • Cancer and Skin Lesions
  • Cancer Cells and Metastasis
  • Cancer Genomics and Diagnostics
  • Metastasis and carcinoma case studies

Best Publications

  • PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

    Yoichi Nagata;Keng Hsueh Lan;Xiaoyan Zhou;Ming Tan

  • Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    Aman U. Buzdar;Nuhad K. Ibrahim;Deborah Francis;Daniel J. Booser

  • Tumour amplified kinase STK15 / BTAK induces centrosome amplification, aneuploidy and transformation

    Hongyi Zhou;Jian Kuang;Ling Zhong;Wen Lin Kuo

  • An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.

    Katherine Stemke-Hale;Ana Maria Gonzalez-Angulo;Ana Lluch;Richard M. Neve

  • Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

    Lin Zhang;Siyuan Zhang;Siyuan Zhang;Jun Yao;Frank J. Lowery

  • Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

    Bryan T. Hennessy;Ana Maria Gonzalez-Angulo;Katherine Stemke-Hale;Michael Z. Gilcrease

  • Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

    Chia Wei Li;Seung Oe Lim;Weiya Xia;Heng Huan Lee

  • IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

    Dung Fang Lee;Hsu Ping Kuo;Hsu Ping Kuo;Chun Te Chen;Chun Te Chen;Jung Mao Hsu;Jung Mao Hsu

  • ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

    Jer Yen Yang;Cong S. Zong;Weiya Xia;Hirohito Yamaguchi

  • Deubiquitination and Stabilization of PD-L1 by CSN5

    Seung Oe Lim;Chia Wei Li;Weiya Xia;Jong Ho Cha

  • AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer

    Krishna M. Vasudevan;David A. Barbie;David A. Barbie;Michael A. Davies;Rosalia Rabinovsky

  • Benign Breast Diseases: Classification, Diagnosis, and Management

    Merih Guray;Aysegul A. Sahin

  • The 2019 World Health Organization classification of tumours of the breast.

    Puay Hoon Tan;Ian Ellis;Kimberly Allison;Edi Brogi

  • Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways

    Siyuan Zhang;Wen Chien Huang;Ping Li;Hua Guo

  • Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance

    Eswaran Devarajan;Aysegul A. Sahin;Jack S. Chen;Raghu R. Krishnamurthy

  • High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

    Ana Maria Gonzalez-Angulo;Jennifer K Litton;Kristine R Broglio;Funda Meric-Bernstam

  • Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ

    Elizabeth Half;Xi Ming Tang;Karin Gwyn;Aysegul A Sahin

  • Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

    Marjorie C. Green;Aman U. Buzdar;Terry Smith;Nuhad K. Ibrahim

  • Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

    Bryan T. Hennessy;Gabriel N. Hortobagyi;Roman Rouzier;Henry Kuerer

  • PTEN activation contributes to tumor inhibition by trastuzumab and loss of PTEN predicts trastuzumab resistance in patients.

    Keng-Hsueh Lan;Yoichi Nagata;Xiaoyan Zhou;Francisco J. Esteva

Frequent Co-Authors

Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Henry Mark Kuerer
Henry Mark Kuerer The University of Texas MD Anderson Cancer Center
Thomas A. Buchholz
Thomas A. Buchholz The University of Texas MD Anderson Cancer Center
Nour Sneige
Nour Sneige The University of Texas MD Anderson Cancer Center
Ana M. Gonzalez-Angulo
Ana M. Gonzalez-Angulo The University of Texas MD Anderson Cancer Center
Elizabeth A. Mittendorf
Elizabeth A. Mittendorf Brigham and Women's Hospital
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Melissa L. Bondy
Melissa L. Bondy Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA offers a wide range of related career options that can be started or advanced through online education. If you’re interested in healthcare but not set on medical school, consider exploring the direct entry nurse practitioner programs for non-nurses online. These programs allow those with a non-nursing bachelor’s degree to fast-track their nursing career.

There are also online adn programs that provide a flexible pathway to become a Registered Nurse, often with fewer admission barriers. For those preferring administrative roles, accredited medical billing and coding schools with financial aid can offer vital skills for the evolving healthcare system at an accessible cost.

Additionally, finding a lpn program without teas test requirements can further simplify entry into the nursing field. Exploring these varied online degrees and certifications can help shape a personalized, rewarding healthcare career from wherever you are.

Best Scientists Citing Aysegul A. Sahin

Trending Scientists

Recently Published Articles